---

Merck and Company Corporate Member, Rahway Merck and Company markets more than 150 prescription pharmaceuticals and vaccines, including cardiovasculars, anti-inflammatories, antibiotics, antibacterials, ophthalmologicals, anti-ulcers, analgesics, muscle relaxants, psychotherapeutics and biologicals. During the past five years alone, the company has developed three new cardiovascular drugs including the breakthrough cholesterol therapy Mevacor, the antibiotic Primaxin, ulcer treatments Pepcid and Losec, urinary tract treatment Noroxin, and the first genetically engineered vaccine for human use, Recombivax HB. Merck spends a higher percentage of its revenues on research than any other drug company, and has also been innovative in making medication available to the people who need it. The Better World Society honored the company with its International Humanitarian Service Medal.